JP2730913B2 - 精製されたＩｇＭ - Google Patents

精製されたＩｇＭ

Info

Publication number
JP2730913B2
JP2730913B2 JP63197281A JP19728188A JP2730913B2 JP 2730913 B2 JP2730913 B2 JP 2730913B2 JP 63197281 A JP63197281 A JP 63197281A JP 19728188 A JP19728188 A JP 19728188A JP 2730913 B2 JP2730913 B2 JP 2730913B2
Authority
JP
Japan
Prior art keywords
igm
antibody
solution
nucleic acid
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63197281A
Other languages
English (en)
Japanese (ja)
Other versions
JPH02493A (ja
Inventor
ジヨージ・ダブ
ゴータム・ミトラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAIRUSU Inc
Original Assignee
MAIRUSU Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAIRUSU Inc filed Critical MAIRUSU Inc
Publication of JPH02493A publication Critical patent/JPH02493A/ja
Application granted granted Critical
Publication of JP2730913B2 publication Critical patent/JP2730913B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1214—Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
JP63197281A 1987-08-10 1988-08-09 精製されたＩｇＭ Expired - Lifetime JP2730913B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8313687A 1987-08-10 1987-08-10
US083136 1987-08-10

Publications (2)

Publication Number Publication Date
JPH02493A JPH02493A (ja) 1990-01-05
JP2730913B2 true JP2730913B2 (ja) 1998-03-25

Family

ID=22176414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63197281A Expired - Lifetime JP2730913B2 (ja) 1987-08-10 1988-08-09 精製されたＩｇＭ

Country Status (8)

Country Link
EP (1) EP0303088B1 (enExample)
JP (1) JP2730913B2 (enExample)
AT (1) ATE82136T1 (enExample)
AU (1) AU618745B2 (enExample)
CA (1) CA1341474C (enExample)
DE (1) DE3875852T2 (enExample)
ES (1) ES2045027T3 (enExample)
GR (1) GR3006536T3 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01197500A (ja) * 1988-01-29 1989-08-09 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
EP0382031A3 (en) * 1989-02-10 1991-06-26 Miles Inc. Monoclonal antibodies in immune serum globulin
CA2049342A1 (en) * 1989-03-27 1990-09-28 Sally Bolmer Formulations for stabilizing of igm antibodies
CA2086531A1 (en) * 1990-07-03 1992-01-04 Ebo S. Bos Immunoreactive compound
JPH0565233A (ja) * 1991-03-08 1993-03-19 Mitsui Toatsu Chem Inc モノクローナル抗体含有凍結乾燥製剤
EP0852951A1 (de) 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
ATE414537T1 (de) 2001-08-29 2008-12-15 Chugai Pharmaceutical Co Ltd Antikörper enthaltende stabilisierte zubereitungen
EP2204190A1 (en) 2003-07-15 2010-07-07 Chugai Seiyaku Kabushiki Kaisha IgM production by transformed cells and methods for quantifying said IgM production
WO2005035573A1 (ja) 2003-10-09 2005-04-21 Chugai Seiyaku Kabushiki Kaisha タンパク質溶液の安定化方法
WO2005035574A1 (ja) * 2003-10-09 2005-04-21 Chugai Seiyaku Kabushiki Kaisha IgM高濃度安定化溶液
AU2011210465A1 (en) * 2010-01-29 2012-08-23 Axis Inc. Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor
US10570194B2 (en) 2015-08-06 2020-02-25 Grifols Worldwide Operations Limited Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)
US20240417445A1 (en) * 2023-06-13 2024-12-19 Grifols Worldwide Operations Limited Method for producing a lyophilized composition comprising polyclonal igm and composition obtained

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4604235A (en) * 1984-05-23 1986-08-05 J. T. Baker Chemical Company Purification of monoclonal antibodies
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Ｅｎｚｙｍｅ Ｍｉｃｒｏｂ．Ｔｅｃｈｎｏｌ．，Ｖｏｌ．９，（１９８７），ｐ．３６１〜３６４
Ｉｍｍｕｎｏｌｏｇｙ，Ｌｅｔｔｅｒｓ，Ｖｏｌ．１４，（１９８７），ｐ．１５９〜１６５．
Ｉｎｆｅｃｔｉｏｎ ａｎｄ Ｉｍｍｕｎｏｌｏｇｙ，Ｖｏｌ．５５，Ｎｏ．５，（１９８７），ｐ．１０５１〜１０５７

Also Published As

Publication number Publication date
ES2045027T3 (es) 1994-01-16
DE3875852D1 (de) 1992-12-17
AU2031588A (en) 1989-06-08
GR3006536T3 (enExample) 1993-06-30
ATE82136T1 (de) 1992-11-15
EP0303088A3 (en) 1989-05-17
EP0303088B1 (en) 1992-11-11
EP0303088A2 (en) 1989-02-15
JPH02493A (ja) 1990-01-05
CA1341474C (en) 2005-03-08
AU618745B2 (en) 1992-01-09
DE3875852T2 (de) 1993-03-18

Similar Documents

Publication Publication Date Title
AU618157B2 (en) Viral inactivation process
USRE43655E1 (en) Chromatographic method for high yield purification and viral inactivation of antibodies
US4318902A (en) Concentrated immunoglobulin solution suited for intravenous administration
US4165370A (en) Injectable gamma globulin
EP0648127B1 (en) Type i surface antigens associated with staphylococcus epidermidis
Frommhagen et al. The role of aggregated γ-globulins in the anticomplementary activity of human and animal sera
CA1302884C (en) Pasteurization of immunoglobulin solutions
CA2015246A1 (en) Human monoclonal antibody, and its production and use
CA1341474C (en) Purified igm
US20030152966A1 (en) Chromatographic method for high yield purification and viral inactivation of antibodies
JPH07267997A (ja) ＩｇＧ− モノクロナール抗体の精製方法及びその使用方法
EP0345543B1 (en) Therapeutic IgM concentrates
JPH10508595A (ja) アジュバント効果を有したキャリアタンパク質、それを含んだ免疫原複合体、その製造方法、ヌクレオチド配列およびワクチン
US5157113A (en) Removal of nucleic acids from monoclonal antibody preparations
AU622446B2 (en) A monoclonal antibody against pseudomonas aeruginosa, the preparation and use thereof
KR100245542B1 (ko) 응고 인자 xiii 또는 xiiia의 정제방법 및 인자 xiiia에 대한 모노클로날 항체
US4564592A (en) Toxoplasmosis factor and production of same
Hausman et al. Alteration of immunoglobulin phenotype in cell culture-adapted lines of two mouse plasmacytomas.
Scherberich et al. Isolation of kidney brush border gamma-glutamyl transpeptidase from urine by specific antibody gel chromatography
JP2656098B2 (ja) 可溶性両親媒性タンパク質ならびにその製造および精製法
Stiehm et al. Some immunologic properties of papain digest fragments of multiple myeloma proteins
JPS61103895A (ja) ＨＢｓＡｇの精製方法
RU2128707C1 (ru) Способ получения поверхностного антигена вируса гепатита в (hbs ag), моноклональные антитела св-hepi, поверхностный антиген вируса гепатита в (hbs ag) и способ получения гибридного клона 48/1/574, продуцирующего моноклональные антитела св-hepi
JPH0339680B2 (enExample)
Sangadala et al. Immunological characterization of deglycosylated human and swine trachea and Cowper's gland mucin glycoproteins

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081219

Year of fee payment: 11

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081219

Year of fee payment: 11